肝脏研究（英文）2025，Vol.9Issue(1)：66-73,8.DOI:10.1016/j.livres.2024.11.003
Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection:A retrospective study in South China
Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection:A retrospective study in South China
Peipei Wang 1Junjian Chen 2Dabiao Chen 1Ziying Lei 1Zhishuo Mo 1Ying Zhang1
作者信息
- 1. Department of Infectious Diseases,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China||Guangdong Provincial Key Laboratory of Liver Disease Research,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China||Key Laboratory of Tropical Disease Control(Sun Yat-sen University),Ministry of Education,Guangzhou,Guangdong,China
- 2. Key Laboratory of Tropical Disease Control(Sun Yat-sen University),Ministry of Education,Guangzhou,Guangdong,China||Institute of Human Virology,Zhongshan School of Medicine(Sun Yat-sen University),Guangzhou,Guangdong,China
- 折叠
摘要
关键词
Hepatitis B virus(HBV)/Coronavirus disease 2019(COVID-19)/Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/Omicron/BA.5/Entecavir(ETV)/Tenofovir(TFV)Key words
Hepatitis B virus(HBV)/Coronavirus disease 2019(COVID-19)/Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/Omicron/BA.5/Entecavir(ETV)/Tenofovir(TFV)引用本文复制引用
Peipei Wang,Junjian Chen,Dabiao Chen,Ziying Lei,Zhishuo Mo,Ying Zhang..Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection:A retrospective study in South China[J].肝脏研究（英文）,2025,9(1):66-73,8.
